Kevin Bell Quoted in Nutritional Outlook Article on FDA’s Final Response to Supplement Industry’s NAC Petitions

Kevin Bell, co-chair of AGG’s Intellectual Property practice and Dietary Supplements industry team, was quoted in a Nutritional Outlook article titled “FDA’s Final Response to Supplement Industry’s NAC Petitions Could Trigger More Legal Action, Rulemaking—and a Fight to Overhaul DSHEA’s Drug Preclusion Clause.”

To read the full article, please click here.